Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dao-Wen Wang

Showing results (1-10 of 519) with videos related to

Pageof 52
Sort By:
Signal Transduction and Targeted Therapy|July 21, 2022
Olfactory receptor 2 activation in macrophages: novel mediator of atherosclerosis progressionZuowen He, Dao Wen Wang
International Journal of Cardiology|April 12, 2020
SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patientsEnrico Ammirati, Dao Wen Wang
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
The roles of eicosanoids in myocardial diseasesZuowen He, Dao Wen Wang
Zhonghua Xin Xue Guan Bing Za Zhi|July 27, 2010
[Association between cytochrome P450 enzymes metabolism and cardiovascular protection]Li Ni, Dao-wen Wang
Current Topics in Medicinal Chemistry|May 22, 2013
CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapyChen Chen, Dao Wen Wang
International Journal of Cardiology. Heart & Vasculature|December 31, 2019
The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fractionXizhen Xu, Dao Wen Wang
Advances in Pharmacology (San Diego, Calif.)|August 3, 2015
Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and CancerChen Chen, Dao Wen Wang
Clinical Cardiology|February 14, 2002
Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree reportDao Wen Wang, You Bin Deng
Molecules (Basel, Switzerland)|June 24, 2022
CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory MediatorsZeqi Shi, Zuowen He, Dao Wen Wang
Frontiers in Pharmacology|April 17, 2024
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acidsShan Jiang, Siyi Han, Dao Wen Wang
Pageof 52

Showing results (1-10 of 519) with videos related to

Sort By:
Pageof 52
Signal Transduction and Targeted Therapy|July 21, 2022
Olfactory receptor 2 activation in macrophages: novel mediator of atherosclerosis progressionZuowen He, Dao Wen Wang
International Journal of Cardiology|April 12, 2020
SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patientsEnrico Ammirati, Dao Wen Wang
Advances in Pharmacology (San Diego, Calif.)|May 26, 2023
The roles of eicosanoids in myocardial diseasesZuowen He, Dao Wen Wang
Zhonghua Xin Xue Guan Bing Za Zhi|July 27, 2010
[Association between cytochrome P450 enzymes metabolism and cardiovascular protection]Li Ni, Dao-wen Wang
Current Topics in Medicinal Chemistry|May 22, 2013
CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapyChen Chen, Dao Wen Wang
International Journal of Cardiology. Heart & Vasculature|December 31, 2019
The progress and controversial of the use of beta blockers in patients with heart failure with a preserved ejection fractionXizhen Xu, Dao Wen Wang
Advances in Pharmacology (San Diego, Calif.)|August 3, 2015
Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and CancerChen Chen, Dao Wen Wang
Clinical Cardiology|February 14, 2002
Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree reportDao Wen Wang, You Bin Deng
Molecules (Basel, Switzerland)|June 24, 2022
CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory MediatorsZeqi Shi, Zuowen He, Dao Wen Wang
Frontiers in Pharmacology|April 17, 2024
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acidsShan Jiang, Siyi Han, Dao Wen Wang
Pageof 52